Eltuhami A. Abdalgadir
Research Subjects
Eltuhami A. Abdalgadir has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Iman K. Abdel Gadir
Department of Biology, College of Science, Jazan University, Jazan, 45142, Saudi Arabia
2 shared publications - Ahmed Shaher Alqahtani
Department of Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jazan University, Jazan, Kingdom of Saudi Arabia
1 shared publication - Amal A. Abdulbaqi
Department of Biology, College of Science, Jazan University, Jazan, Saudi Arabia
1 shared publication - Amal Naif Alshammari1 shared publication
- Amani Alhejely
Department of Biology, University College in Darb, Jazan University, Jazan, Saudi Arabia
1 shared publication - Asaad Khalid
Health Research Centre, Jazan University
1 shared publication
Latest Publications
- Open Access
- 17 September 2025
- Published by Elsevier in Journal of Radiation Research and Applied Sciences
- Vol. 18 (4)
Dual therapeutic potential of ethanolic plant extracts in diabetes and liver cancer: Comparative study with liraglutide and doxorubicin
- 17 September 2025
- Published by Elsevier in Journal of Radiation Research and Applied Sciences
- Vol. 18 (4)
Open AccessDual therapeutic potential of ethanolic plant extracts in diabetes and liver cancer: Comparative study with liraglutide and doxorubicin
- Open Access
- 1 January 2024
- Published by Wiley in Journal of Spectroscopy
- Vol. 2024 (1)
GC‐MS Profiling and Therapeutic Potentials of Prosopis juliflora (Sw.) DC: Cytotoxic and Antimicrobial Insights
Plants belonging to the genus Prosopis L. (family Fabaceae, subfamily Mimosoideae) have gained significant popularity in traditional medicine due to their potential as anticancer, antidiabetic, anti‐inflammatory, and antibacterial compounds. The primary objective of this work was to determine the phytochemical composition of the ethanolic extract derived from Prosopis juliflora leaves, as well as to assess its antibacterial and cytotoxic properties. The phytochemical screening using GC‐MS revealed the presence of phytosteroids, ketone, esters, diisooctyl phthalate, and triterpenes. Besides, varying amounts of some silicon derivatives, which were reported to have antimicrobial activity, were detected with octasiloxane, which showed the highest amount (18.47%). 6‐Ethoxy‐6‐methyl‐2‐cyclohexenone (antioxidant, antidiabetic, antiobesity, and antimicrobial) was detected in considerable quantity. Cytotoxic activity was seen in human breast cancer (MCF‐7), human ovary adenocarcinoma (A2780), and human colon adenocarcinoma (HT‐29) cell lines, as well as in normal human fetal lung fibroblasts (MRC‐5), when subjected to the MTT assay. The plant extract exhibited the highest level of activity (5.75 μg/mL) against the A2780 cell line, with the MCF‐7 cell line showing a somewhat lower level of activity (18.49 μg/mL). The antibacterial effect of the plant extracts was evaluated against four standard Gram‐positive and four standard Gram‐negative. The antimicrobial potential was observed only against Staphylococcus aureus which recorded a 14.5 ± 0.05 mm inhibition zone. The present study has demonstrated the identification of bioactive constituents in P. juliflora plant extracts, which exhibit significant cytotoxic activity against breast and colon malignancies. The study also highlighted P. juliflora extract as an antibacterial against S. aureus.
- 1 January 2024
- Published by Wiley in Journal of Spectroscopy
- Vol. 2024 (1)
Open AccessGC‐MS Profiling and Therapeutic Potentials of Prosopis juliflora (Sw.) DC: Cytotoxic and Antimicrobial Insights
Plants belonging to the genus Prosopis L. (family Fabaceae, subfamily Mimosoideae) have gained significant popularity in traditional medicine due to their potential as anticancer, antidiabetic, anti‐inflammatory, and antibacterial compounds. The primary objective of this work was to determine the phytochemical composition of the ethanolic extract derived from Prosopis juliflora leaves, as well as to assess its antibacterial and cytotoxic properties. The phytochemical screening using GC‐MS revealed the presence of phytosteroids, ketone, esters, diisooctyl phthalate, and triterpenes. Besides, varying amounts of some silicon derivatives, which were reported to have antimicrobial activity, were detected with octasiloxane, which showed the highest amount (18.47%). 6‐Ethoxy‐6‐methyl‐2‐cyclohexenone (antioxidant, antidiabetic, antiobesity, and antimicrobial) was detected in considerable quantity. Cytotoxic activity was seen in human breast cancer (MCF‐7), human ovary adenocarcinoma (A2780), and human colon adenocarcinoma (HT‐29) cell lines, as well as in normal human fetal lung fibroblasts (MRC‐5), when subjected to the MTT assay. The plant extract exhibited the highest level of activity (5.75 μg/mL) against the A2780 cell line, with the MCF‐7 cell line showing a somewhat lower level of activity (18.49 μg/mL). The antibacterial effect of the plant extracts was evaluated against four standard Gram‐positive and four standard Gram‐negative. The antimicrobial potential was observed only against Staphylococcus aureus which recorded a 14.5 ± 0.05 mm inhibition zone. The present study has demonstrated the identification of bioactive constituents in P. juliflora plant extracts, which exhibit significant cytotoxic activity against breast and colon malignancies. The study also highlighted P. juliflora extract as an antibacterial against S. aureus.